There are few reports published in Japan on canine allergenimmunotherapy and its effectiveness. This therapy is a drastic treatment, in which sentitized antigens identified by intrademal skin tests are injected repeatedly, and makes the recipients acquire allergic resistance. In this paper, we report the results of using allergenimmunotherapy to treat 23 dogs with atopic dermatitis. For five of the dogs, the treatment was discontinued within one year because of the owners' decision or for financial reason, so they were eliminated from the statistic. Eighteen of the dogs received the therapy for more than a year. The skin condition of each dog was evaluated and classified into four grades. This therapy was highly effective for five dogs, effective for seven dogs, insufficiently effective for four dogs, and ineffective for the remaining two. One dog classified as effective showed a slight side effect only once, a year after the therapy was initiated. Effectiveness of the therapy was calculated to be 67%, which is almost the same as reported in previous papers.
View full abstract